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CX3CR1 deficiency promotes muscle repair and
regeneration by enhancing macrophage ApoE
production
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Muscle injury triggers inflammation in which infiltrating mononuclear phagocytes are crucial
for tissue regeneration. The interaction of the CCL2/CCR2 and CX3CL1/CX3CR1 chemokine
axis that guides phagocyte infiltration is incompletely understood. Here, we show that
CX3CR1 deficiency promotes muscle repair and rescues Ccl2 / mice from impaired muscle
regeneration as a result of altered macrophage function, not infiltration. Transcriptomic
analysis of muscle mononuclear phagocytes reveals that Apolipoprotein E (ApoE) is
upregulated in mice with efficient regeneration. ApoE treatment enhances phagocytosis by
mononuclear phagocytes in vitro, and restores phagocytic activity and muscle regeneration in
Ccl2 / mice. Because CX3CR1 deficiency may compensate for defective CCL2-dependant
monocyte recruitment by modulating ApoE-dependent macrophage phagocytic activity,
targeting CX3CR1 expressed by macrophages might be a powerful therapeutic approach to
improve muscle regeneration.
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M
onocytes are key players during trauma and inflamma-
tion, whereas tissue-resident macrophages have an
important role during tissue homeostasis and the
resolution of inflammation. However, it is not well established
how monocytes and macrophages contribute to both protective/
regenerative features and deleterious pathogenic processes.
Therefore, defining the molecular and cellular processes that
enhance, limit or resolve inflammation may lead to useful
therapy. Muscle damage induces massive macrophage infiltration
at the injury site, and macrophages are essential for muscle
regeneration1–4. Indeed, partial depletion of mononuclear
phagocytes impairs muscle regeneration, whereas reconstitution
of myeloid lineage restores regeneration2,5,6. We previously
showed that injured skeletal muscle recruits monocytes
exhibiting inflammatory profiles that operate phagocytosis and
rapidly convert to anti-inflammatory mononuclear phagocytes3.
Aside from removing necrotic muscle debris, macrophages
promote myogenic cell growth and differentiation by releasing
growth factors and cytokines7,8, protect myogenic cells from
apoptosis9 and participate in restoring perfusion by promoting
collateral artery formation and angiogenesis10. In mice,
infiltrating macrophages differentiate from circulating
inflammatory Ly6Chigh monocytes that co-express CCR2 and
CX3CR1, two important chemokine receptors involved in
monocyte motility2,3,11. In mice lacking CCR2 (Ccr2 / ) or
its cognate ligand (Ccl2 / ), muscle regeneration and
macrophage infiltration are impaired, and macrophage
activation is modified5,6,12–16. By contrast, the role of CX3CR1
in muscle healing has not been defined yet, despite its importance
in monocyte recruitment17,18, macrophage polarization19–22, cell
survival20,23 and angiogenesis24,25.
In the skeletal muscle, recent works indicated that CX3CR1-
negative resident macrophages localized in the normal epimy-
sium/perimysium behave as sensors of pathological events,
whereas exudate CX3CR1-expressing mononuclear phagocytes
may provide immediate inflammatory response in the injured
muscle and longstanding immune surveillance until full muscle
restoration26. CX3CR1 is not recognized as a key molecule in
resident macrophage ontogeny, although it plays a key role in
kidney dendritic cells, brain microglial cells and intestinal
macrophages colonization27–29. Few studies indicate that the
survival of monocytes and tissue macrophages may rely on
CX3CR1 as shown within the atherosclerotic plaques30 and in the
liver20. More recently, CX3CR1 was identified as a regulator of
renal macrophage proliferation31.
Chemokine (CX3C motif) ligand 1 (CX3CL1) also known as
fractalkine or neurotactin is the only known member of the CX3C
class of chemokines. It is unique because (i) it is expressed both as
a membrane-bound and a soluble form and (ii) it binds
specifically to its receptor CX3CR1. It is expressed by human
and murine primary myoblasts in culture32,33. Whether the
CX3CR1/CX3CL1 axis is involved in muscle healing through the
recruitment of circulating monocytes or the activation of
macrophages, and whether its relation to the CCL2/CCR2 axis
is unequivocal, as in atherosclerosis18,34, or ambiguous, as in age-
related macular degeneration (AMD)35, remains to be
understood.
In this study, we investigate muscle regeneration and
mononuclear phagocyte recruitment in a notexin-induced
muscle injury model by comparing C57Bl/6 (wild type, WT),
Cx3cr1 / , Ccl2 / and Cx3cr1 / Ccl2 / mice. We show
that CX3CR1 deficiency promotes muscle repair and rescues
Ccl2 / mice from impaired muscle regeneration. These
phenomena result not from altered mononuclear phagocyte
infiltration in Cx3cr1 / mice but from functional modifica-
tions. Transcriptomic analysis were performed to compare
muscle mononuclear phagocyte subsets between mice
with efficient regeneration (WT, Cx3cr1 / and Cx3cr1 /
Ccl2 / mice) and those with poor recovery (Ccl2 / mice).
Among genes differentially expressed, Apolipoprotein E (ApoE)
transcripts are downregulated in Ccl2 / mononuclear phago-
cyte subsets. Both ApoE administration and ApoE-proficient
bone marrow (BM) transfer restore muscle regeneration in
Ccl2 / mice. CX3CR1-ApoE-deficient BM transfer did not
rescue CCL2-delayed muscle regeneration as effectively as
CX3CR1-deficient ApoE-proficient transfer. Finally, ApoE
enhances in vitro phagocytosis by macrophages, restores
phagocytic activity in Ccl2 / mice, and its deficiency leads to
incomplete necrotic myofiber removal. Our results suggest that
targeting CX3CR1 expressed by mononuclear phagocytes might
be useful in alleviating inflammation and promoting muscle
regeneration after trauma.
Results
CX3CR1 deficiency promotes muscle healing after injury. We
used a mouse model of notexin-induced muscle injury to analyse
the muscle reparative process and mononuclear phagocyte
recruitment. We show that CX3CR1 (Supplementary Fig. 1a,b)
and its ligand CX3CL1 (Supplementary Fig. 1c) are both expre-
ssed during muscle regeneration with a maximum reached at day
4. Concomitantly, CCL2 was secreted at days 1 and 4 post injury
(Supplementary Fig. 1d). To understand the roles of these che-
mokines and their functional relationship during muscle repair,
we compared muscle regeneration events and mononuclear
phagocyte recruitment between C57Bl/6 (WT), Cx3cr1 / ,
Ccl2 / and Cx3cr1 / Ccl2 / mice. Notexin induced
muscle necrosis (day 1, data not shown), which was followed by
leukocyte infiltration (day 4), regenerating myofiber formation
(day 10) and myofiber growth (day 21; Fig. 1a). Consistent with
published data16, muscle regeneration was impaired in Ccl2 /
mice compared with WT mice and was characterized by delays in
necrotic fibre removal and myofiber regeneration (Fig. 1a,b and
Supplementary Fig. 2), a smaller cross-sectional area (CSA) of
regenerating myofibers (Fig. 1c), more intermuscular adipocytes
(Fig. 1d), calcification (Fig. 1e) and fibrosis (Fig. 1f), as well as
decreased neovascularization (Fig. 1g). CX3CR1 deficiency
improved muscle regeneration: Cx3cr1 / mice had fewer
necrotic and more regenerating myofibers on day 4 (Fig. 1a,b and
Supplementary Fig. 2), higher myofiber CSA on days 10 and 21
post injury (Fig. 1c) and reduced intermuscular calcification
(Fig. 1e). Strikingly, muscle regeneration in Cx3cr1 / Ccl2 /
mice was better than in Ccl2 / mice and similar to that of WT
mice for all the indicators studied; it thus enhanced the muscle
regeneration improvement driven by the CX3CR1 deficiency
(Fig. 1 and Supplementary Fig. 2). These results were unexpected,
as CX3CR1 deficiency usually causes severe disorders in various
inflammatory models, associated with cell death36, fibrosis
development20, delayed wound healing and
neovascularization24,25. The observation of the rescued
phenotype in both male and female double-deficient mice
(Supplementary Fig. 3) but not in Cx3cr1 / Ccr2 /
compared with Ccr2 / mice (Supplementary Fig. 4) suggests
that a minimum level of monocyte infiltration is required
to compensate for the muscle regeneration impairment
(monocyte recruitment is more severely impaired in Ccr2 /
than Ccl2 / mice12). CX3CR1 deficiency thus appears to
promote muscle repair and rescue Ccl2 / mice from impaired
muscle regeneration.
CCL2 but not CX3CR1 deficiency alters macrophage infiltration.
To identify the cellular origin of the muscle regeneration rescue
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observed in Cx3cr1 / Ccl2 / mice, we performed BM
transplantation experiments in sub-lethally irradiated Ccl2 /
mice. The control graft produced strongly improved muscle
regeneration on day 10 post injury, characterized by increased
regenerating myofiber CSA and decreased intermuscular fat
accumulation and calcification (Fig. 2a). BM transfer from
Cx3cr1 / mice amplified muscle regeneration rescue and
increased the regenerating myofiber CSA. This indicates that the
muscle regeneration improvement observed in Cx3cr1 / mice
relied on BM-derived cells.
As both CX3CR1 and CCL2 are involved in mononuclear
phagocyte trafficking, we hypothesized that modulation of
mononuclear phagocyte recruitment in the injured muscle might
account for the improved regeneration in Cx3cr1 / mice and
rescue of Cx3cr1 / Ccl2 / mice. We assessed mononuclear
phagocyte infiltration throughout the injured muscle by flow
cytometry (Fig. 2b) and identified four distinct populations
(subsets 1–4) expressing typical mononuclear phagocyte pheno-
typic markers (CD11bþ Ly6G NK1.1 F4/80þ Mgl1þ ;
Fig. 2b and Supplementary Fig. 5). Subset 1 (F4/80low Ly6Chigh)
has bean-shaped nuclei and may correspond to infiltrating
Ly6Chigh blood monocytes. Subset 2 (F4/80low Ly6Clow)
expressed dendritic cell markers, such as CD11c and IAb (major
histocompatibility complex molecules-class II), and CD64
(FcgRI) at lower levels than the other three subsets. Cells from
subsets 3 and 4 were larger and had typical macrophage
morphology; subset 3 (F4/80high Ly6Clow Mgl1low) expressed
lower levels of M2-type macrophage markers (such as
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Figure 1 | CX3CR1 deficiency promotes and rescues Ccl2 / muscle healing after injury. Muscle regeneration was assessed after notexin injury in WT,
Cx3cr1 / , Ccl2 / and Cx3cr1 / Ccl2 / mice on days 4, 10 and 21 post injury. (a) Haematoxylin/eosin staining of uninjured and regenerating
muscle ( 100 magnification, scale bar, 100mm). Arrows indicate dense violet structures corresponding to calcified myofibers, and arrowheads mark
intermuscular adipocytes (transparent monovacuolar cells). (b) Quantification of regeneration on day 4 post injury assessed by the percentage of
necrotic (infiltrated or not) and regenerating (basophilicþ centrally nucleated) myofibers, expressed as a percentage of the total number of myofibers.
(c) Quantification of the mean cross-sectional area (CSA) of regenerating myofibers, by image J software. (d) Oil Red O staining of lipids within
intermuscular adipocytes, (e) Alizarin Red staining of calcified myofibers, (f) Masson Trichrome staining of connective tissue and quantification of the
different areas, by setting appropriate thresholds on image J software. Fat, calcification and fibrosis are expressed as percentages of the total injured area
(between 60 and 90% of total muscle surface) and results are a mean of three different muscle cross-sections taken at each end and the middle of the
muscle. (d, e and f: scale bar, 100mm). (g) Vascularization was quantified on muscle cross-sections stained with wheat germ/Griffonia simplicifolia
agglutinin (scale bar, 50mm). Data are meanþ s.e.m. of six mice per strain, which represent two distinct experiments. NS, not significant, *Po0.05,
**Po0.01 and ***Po0.001 for each knock-out strain versus WT and for Ccl2 / versus Cx3cr1 / Ccl2 / mice.
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Mgl1 and CD206) than subset 4 (F4/80high Ly6Clow Mgl1high;
Fig. 2b and Supplementary Fig. 5). Cells from subsets 1 and 3
were the main mononuclear phagocyte subsets (about 86%) in
muscle at the peak of inflammation, on day 4 post injury (Fig. 2c).
In a previous study2, we showed that Ly6C high monocytes in the
muscle are recruited from the blood and are non-dividing cells.
They switched their phenotype to Ly6Clow mononuclear
phagocytes and actively proliferated in situ, contributing to the
large amount of mononuclear phagocytes observed in the muscle
at day 4 post injury.
Subset 1 was found in significantly lower numbers on day 1
(70% reduction, Po0.0006) as was subset 3 on day 4 (48%
reduction, Po0.0001) in injured muscles from Ccl2 / and
Cx3cr1 / Ccl2 / compared with WT and Cx3cr1 / mice
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Figure 2 | CCL2 but not CX3CR1 deficiency affects macrophage recruitment in muscle. (a) Analysis of muscle regeneration in chimeric Ccl2 / mice
engrafted with bone marrow from Ccl2 / , WTand Cx3cr1 / mice, by measuring the mean regenerating myofiber CSA and the areas of intermuscular
adipocyte and of calcified myofibers on day 10 post injury. ***Po0.001 for Ccl2 / mice engrafted with bone marrow fromWTor Cx3cr1 / mice versus
Ccl2 / mice engrafted with Ccl2 / bone marrow. Data are mean of a single experimentþ s.e.m. of three mice per strain. (b) Gating strategy for
macrophages on day 4 post injury. Macrophages expressed CD11b, F4/80 and Mgl1 but not Ly6G or NK1.1. Four subsets of cells corresponding to this
phenotype were identified; a subset of CD11bþ F4/80þ Ly6Clow Mgl1 cells, with morphology typical of eosinophils, was excluded from the analysis.
(c) Proportion of each macrophage subset on day 4 post injury. (d) Kinetics of the four macrophage subsets during muscle regeneration in WT, Cx3cr1 / ,
Ccl2 / and Cx3cr1 / Ccl2 / mice. *Po0.05 for Ccl2 / and Cx3cr1 / Ccl2 / strains versus WT. Data are mean of two to four distinct
experiments±s.e.m. of at least six mice per strain per time point. (e) The four macrophage subsets from injured muscle were sorted by flow cytometry on
day 4 post injury according to the gating strategy described in (b). RNA from one cell-sorting experiment, representing a pool of three mice per strain, was
amplified and hybridized on the Illumina whole mouse genome oligo microarrays (WG6). Hierarchical clustered heat map of macrophage subsets 1, 2, 3
and 4 based on the gene expression of ten different clusters. Red: increased expression, green: decreased expression.
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(Fig. 2d). This finding confirms that monocyte/macrophage
recruitment requires CCL2 (ref. 12). Conversely, CCL2 and
CX3CR1 deficiency did not or only slightly affected the
proportions of subsets 2 and 4. The greater impairment of the
recruitment of subsets 1 and 3 in the injured muscle of Ccr2 /
mice (Supplementary Fig. 6) suggests that their presence in the
lesion is necessary for the CX3CR1-dependent compensatory
effect. Strikingly, the infiltration kinetics of all mononuclear
phagocyte subsets of Ccl2 / and Cx3cr1 / Ccl2 / mice,
as for WT and Cx3cr1 / mice, were superimposable (Fig. 2d)
despite strongly different pathophysiological conditions. The
apparent lack of association between the muscle regeneration
rescue observed in Cx3cr1 / Ccl2 / mice and any change in
the number of monocytes infiltrating/macrophages proliferating
in the injured muscle suggests that the process allowing muscle
recovery in Cx3cr1 / mice may be related to mononuclear
phagocyte functions. We next investigated the role of BM-derived
macrophages from the various mice strains regarding myogenic
precursor cells (MPCs) using in vitro assays. No differences were
observed in MPC proliferation or fusion (Supplementary Fig. 7).
Neither CX3CR1 nor CCR2 were detected on satellite cells13, on
myoblasts or on regenerating myofibers (data not shown).
To address more globally the mononuclear phagocyte func-
tions that may promote muscle regeneration, we performed a
genome-wide microarray analysis of the four mononuclear
phagocyte subsets from WT, Cx3cr1 / , Ccl2 / and
Cx3cr1 / Ccl2 / muscles on day 4 post injury
(GSE73473). One-way analysis of variance analysis identified
434 genes (Po0.05) that distinguished the four subsets (Fig. 2e).
Using hierarchical clustering and pathway analysis, we identified
10 clusters that confirmed the original identity and functions of
each subset. Because muscle regeneration was not rescued
in Cx3cr1 / Ccr2 / mice (Supplementary Fig. 4) and
muscle infiltration of subsets 1 and 3 was fully abrogated
only in Ccr2 / mice (Supplementary Fig. 5), we postulated
that these subsets were mainly responsible for this rescued
phenotype and sought to identify in them the genes that promote
healing.
ApoE production is adversely regulated by CCL2 and CX3CR1.
Comparison of the mononuclear phagocyte transcriptomic pro-
files from mice with poor regenerative abilities (Ccl2 / ) and
from mice with effective muscle healing (WT, Cx3cr1 / and
Cx3cr1 / Ccl2 / ) identified 22 and 17 genes significantly
differentially expressed in mononuclear phagocyte subsets 1 and
3, respectively (Fig. 3a,b). Among them, only ApoE transcripts
were downregulated in both Ccl2 / subsets 1 and 3. We con-
firmed severely lower ApoE expression in macrophages isolated
from injured muscle of Ccl2 / mice at both RNA (Fig. 3c) and
protein levels (Fig. 3d,e and Supplementary Fig. 8). In accordance
with the microarray data, ApoE expression was restored in
Cx3cr1 /Ccl2 / mice. Moreover, we found a higher
expression of ApoE in mononuclear phagocytes from CX3CR1-
deficient compared with CX3CR1-proficient mice (Fig. 3c–e). We
also showed that addition of CX3CL1 on WT macrophages
in vitro suppressed ApoE expression by about 30%, without
affecting CCL2 expression (Fig. 3f). These results reveal that
CX3CL1/CX3CR1 axis is also directly involved in the regulation
of ApoE expression.
Interestingly, most of the dysregulated genes in mononuclear
phagocytes from Ccl2 / versus WT, Cx3cr1 / and
Cx3cr1 / Ccl2 / mice can be linked in a network in which
ApoE is central and related to inflammatory response, endocy-
tosis signalling and the LXR/RXR activation pathway involved in
the regulation of inflammation and lipid metabolism37 (Fig. 3g).
We previously published a functional link between ApoE and
CX3CR1 in AMD38. Sub-retinal macrophages in AMD patients as
well as in sub-retinal inflammation observed in Cx3cr1 / mice
express high levels of ApoE. Previous studies indicate that ApoE
is an immunomodulatory agent that polarizes macrophages in a
M2 anti-inflammatory phenotype39. We previously showed that
M2 macrophages are associated with myofiber growth and
myoblast differentiation and fusion3. In addition, ApoE can
suppress the pro-inflammatory response mediated by microbial
stimuli in vivo40,41. Furthermore, the delay in skeletal muscle
healing in ApoE / mice following hindlimb ischaemia-
reperfusion42 suggests that this gene plays a major role in the
muscle regeneration process.
ApoE favours phagocytosis and muscle regeneration. Histolo-
gical analysis of injured muscle from ApoE / mice 10 days
after injury revealed strongly impaired muscle regeneration, with
a markedly lower CSA of regenerating myofiber and increased
intermuscular fat and calcification (Fig. 4a). These results are
consistent with previous reports that ApoE / mice develop
calcification and accumulate lipid-filled foam cells within
atheromatous plaque when fed a high-fat diet43,44. Using
hydrodynamic-based in vivo transfection, we next showed that
systemic expression of human ApoE3 improved muscle repair in
Ccl2 / mice (Fig. 4b). In addition, Cx3cr1 / ApoE /
bone-marrow transfer in irradiated Ccl2 / mice did
not promote myofiber growth as effectively as Cx3cr1 /
bone-marrow transfer (þ 33% myofiber CSA versus þ 58%;
Fig. 4c). We also observed high reduction of myofiber
growth in Cx3cr1 / Ccl2 / ApoE / mice compared
with Cx3cr1 / Ccl2 / mice (Fig. 4d). These results
demonstrate that the impairment of muscle regeneration in
Ccl2 / mice depends at least partially on the inability of muscle
mononuclear phagocytes to produce enough ApoE and that
CX3CR1 deficiency promotes and rescues Ccl2 / muscle
healing by regulating ApoE production by macrophages.
Because macrophage phagocytic activity is impaired in
ApoE / (Supplementary Fig. 9) and improved in Cx3cr1 /
mice21,45, we hypothesized that improved muscle regeneration in
Cx3cr1 / mice and rescue in Cx3cr1 / Ccl2 / mice might
be linked to increased phagocytosis, and indeed we measured
more phagocytic activity in muscles from Cx3cr1 / compared
with WT mice (Fig. 5a). The better necrotic myofiber removal in
Cx3cr1 / Ccl2 / compared with Ccl2 / mice (for an
equivalent number of infiltrated mononuclear phagocytes)
suggests that CX3CR1-deficient mononuclear phagocytes
have higher phagocytic activity. Ex vivo experiments confirmed
that muscle macrophages from Cx3cr1 / and Cx3cr1 /
Ccl2 / mice engulfed fluorescent microspheres more
effectively than those from Ccl2 / animals (Fig. 5b).
Moreover, addition of exogenous APOE3 improved both
phagocytic activity of Ccl2 / muscle macrophages in vitro
(Fig. 5c) and necrotic myofibre removal in Ccl2 / mice
(Fig. 5d). Addition of CCL2 restored phagocytic activity of
Ccl2 / macrophages (Fig. 5e, right panel) but not that of WT
and Cx3cr1 / macrophages. A reduction in WT macrophage
phagocytic capacity was observed after incubation with CX3CL1
(Fig. 5e, left panel). Finally, the addition of CX3CL1 and CCL2 on
WT macrophage-enriched muscular cell suspensions triggered
similar expression of molecules involved in inflammatory
response such as IL-1b, IL-1RA (IL-1 receptor antagonist) and
iNOS (inducible nitric oxide synthase; Fig. 5f). Altogether, our
results suggest that impaired muscle healing in Ccl2 / mice is
linked to decreases in monocyte/macrophage recruitment and
function, notably phagocytosis.
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Discussion
Skeletal muscle regeneration is a complex series of events, in
which monocytes/macrophages play a major part in the healing
process. Chemokines and their receptors orchestrate their
distribution and their functions to ensure muscle regeneration.
CX3CR1 and CCL2 deficiencies affect post-lesion blood mono-
cytosis differently: CX3CR1 deficiency is associated with a
reduction in Ly6Clow monocytes, whereas CCL2 deficiency affects
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the number of Ly6Clow and Ly6Chigh monocytes (Supplementary
Fig. 10). Because Ly6Clow blood monocytes have no role in the
muscle regeneration process3,46, their lack may not impair this
process. Few groups including Saederup et al.47 and our group18
have shown additive or synergistic effects of CCR2 and CX3CR1
axis on monocyte recruitment or macrophage accumulation.
CCR2 and CX3CR1 axis may also lead to the opposite effect, and
more specifically CX3CR1 deficiency may promote CCR2-
dependent microglial cell accumulation in the retina35. Here we
could not detect any changes in monocyte recruitment or in
macrophage accumulation consistently with our previous work
showing that monocyte recruitment in the injured muscle was
exclusively dependent on CCR2 axis3. In these conditions,
CX3CR1 may only affect macrophage functions, not monocyte
recruitment or macrophage proliferation.
CX3CR1 is an essential pleiotropic chemokine receptor
involved in various biological functions, including cell chemo-
taxis, apoptosis, cell activation/polarization, organ development
and neovascularization. Its deficiency is considered deleterious in
a large variety of acute inflammatory responses where it
exacerbates inflammation20,24,36. In chronic diseases, such as
atherosclerosis, CX3CR1 deficiency also limits monocyte
recruitment and macrophage accumulation at inflammatory
sites leading to reduced atherosclerosis18,48,49. In contrast,
CX3CR1 presence is somewhat protective in AMD50. The
role of CX3CR1 appears to be different depending on the
inflammatory model. Our results show for the first time that
CX3CR1 deficiency can improve wound healing in an acute
injury model without affecting monocyte recruitment or
macrophage accumulation. In the mdx mice, a chronic model
of muscle injury (a murine model for Duchenne muscular
dystrophy), previous studies using gene expression microarrays
have demonstrated that dystrophic muscles are characterized by
an inflammatory ‘molecular signature’51,52, in which CC
chemokines are prominent and among which CCL2 and its
receptor CCR2 are highly expressed53,54. There is no evidence of
CX3CR1/CX3CL1 expression in this context and the role of
CX3CR1 has not yet been investigated. In a previous work9, we
showed that four molecular systems including CX3CR1/CX3CL1
are involved in MPC apoptosis inhibition driven by macrophages
in vivo and in vitro. Although apoptosis induction is fairly easy to
achieve in vitro (through the incubation with various
pro-apoptotic drugs), the MPC apoptosis events in vivo are
rather rare, with apoptotic MPC representing only a very small
number of cells in the myoblast population. In contrast,
phagocytosis events during muscle repair are ubiquitous, and it
is more likely that macrophages will engulf apoptotic MPC in vivo
than protect them through the CX3CR1/CX3CL1 molecular
system.
Figure 6 summarizes the main findings of the work and
proposes a model of action of macrophages in muscle regeneration
via ApoE production. We demonstrated that CX3CR1 deficiency is
associated with increased removal of necrotic myofibers, as it is
with the phagocytosis of amyloid-beta deposits in the brain of a
murine model of Alzheimer’s disease21. Similarly, CX3CR1-
deficient mononuclear phagocytes overexpressed ApoE protein,
which is known to stimulate macrophage phagocytosis and
dampen inflammatory response39,45. Moreover, a recent study38
demonstrated a link between ApoE and CX3CR1 in AMD. Sub-
retinal macrophages in AMD patients as well as in sub-retinal
inflammation observed in Cx3cr1 / mice express high levels
of ApoE. In addition, ApoE deletion in Cx3cr1 / mice
prevents pathogenic- and stress-induced subretinal macrophage
accumulation. Here we showed that the exogenous administration
of ApoE enhanced CCL2-deficient mononuclear phagocyte
phagocytic activity. These results suggest that defective CCL2-
dependent monocyte recruitment may be compensated by
CX3CR1 deficiency through the modulation of ApoE-dependent
macrophage phagocytic activity. Therefore, therapeutic
intervention to improve mononuclear phagocyte functions by
targeting the CX3CR1 chemokine axis might control inflammation
and enhance muscle regeneration in response to injury.
Methods
Mice. Experiments were conducted on adult female and male mice (8–16 weeks
old) of the following strains (all on a C57Bl/6J genetic background): C57Bl/6J
(WT; purchased from Janvier), Cx3cr1 / (ref. 55), Ccl2 / (#004434, JAX),
Ccr2 / (#004999, JAX), ApoE / (#002052, JAX), Cx3cr1gfp/þ (#008451, JAX)
were intercrossed to obtain Cx3cr1 / Ccl2 / , Cx3cr1 / ApoE / ,
Cx3cr1 / Ccl2 / ApoE / and CX3CR1gfp/gfp ApoE / as described
in ref. 18. Mice were bred and maintained in our specific pathogen-free animal
facility according to institutional guidelines and used according to the French
legislation (no. A-75-1315). All experiment protocols were approved by the local
ethics committee and validated by the Service Protection et Sante´ Animales,
Environnement (no. A-75-2065).
Muscle injury. Muscle injury was caused by intramuscular injection of 10 ml of
notexin (25 mgml 1 in PBS; Latoxan) into the tibialis anterior (TA) muscle.
Muscle and fascia were harvested together for analysis at different time points post
injury (1, 4, 7, 10, 14, 21 days). In some experiments, a pLIVE plasmid encoding for
human ApoE3 was injected into mouse tail veins 6 h before muscle injury.
Histological analysis. TA muscles were removed, snap frozen in nitrogen-chilled
isopentane and kept at  80 C until use for histological analysis. Cryosections of
7 mm thick were prepared for various types of histological staining. Muscle
regeneration was analysed quantitatively for the entire injured area (between 60
and 90% of the entire muscle). The percentages of necrotic and regenerating
myofibers as well as the CSA of the regenerating myofibers, an established
indicator, were quantified on haematoxylin/eosin-stained muscle sections recorded
with an Olympus BX51 at  10 magnification, connected to an evolution VF
camera (medicaCybernetics). We used image J software to count three fields always
chosen in the same overall injured area (representing 660±150 myofibers) for at
least six different mice analysed per time point. Regenerating myofiber density was
assessed in the same fields and is expressed as the number of regenerating
myofibers per field. Phagocytosis was assessed on day 4 post injury on muscle
cross-sections stained with haematoxylin/eosin by counting the ratio of infiltrated
to non-infiltrated necrotic myofibers. Vascularization was quantified on muscle
cross-sections stained with wheat germ/Griffonia simplicifolia agglutinin. We
counted 8±1 fields (at  20 magnification) chosen randomly over the entire
injured area and representing 485±160 myofibers, in three different mice. Areas of
fat, calcification and fibrosis were evaluated over the entire injured area of three
muscle cross-sections at levels spaced 900mm apart, stained, respectively, with Oil
Red O, Alizarin Red and Masson Trichrome and recorded with a Nikon AZ100
macroscope connected to a DS-Ri1 camera (Nikon). Appropriate thresholds were
set with image J software to evaluate these areas. Each parameter was studied on
days 4 (except fibrosis), 10 and 21 post injury in at least six different mice.
Isolation of leukocytes and macrophages from muscle. Mice were flushed with
10ml of PBS to remove blood. Muscles and fascia were weighed together, minced
Figure 4 | Macrophage ApoE production improves skeletal muscle regeneration. (a) Analysis of muscle regeneration of ApoE / (n¼ 11) versus WT
mice (n¼ 7) on day 10 post injury, by measurement of mean CSA of regenerating myofibers, myofiber density and areas of fat and calcification. Data are
meanþ s.e.m. of two distinct experiments. (b) Analysis on day 10 post injury of muscle regeneration in Ccl2 / mice, transfected (n¼ 3) or not (n¼ 3)
with a pLIVE plasmid encoding for human ApoE3, by measurement of mean CSA of regenerating myofibers, myofiber density and areas of fat and
calcification. In this experimental system, systemic expression of ApoE3 was detected for at least 8 days after transfection (data not shown). Data are
meanþ s.e.m. of a single experiment. Scale bar, 100mm. (c) Analysis of muscle regeneration in chimeric Ccl2 / mice engrafted with Ccl2 / (n¼ 5),
Cx3cr1 / (n¼ 5) or Cx3cr1 / ApoE / (n¼4) bone marrow, by measurement of the mean CSA of regenerating myofibers on day 21 post injury.
(d) Analysis of muscle regeneration in Cx3cr1 / Ccl2 / mice (n¼4) and Cx3cr1 / Ccl2 / ApoE / mice (n¼4). Data are meanþ s.e.m.;
NS, not significant, *Po0.05, **Po0.01 and ***Po0.001.
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and digested twice for 45min each time in DMEM containing collagenase B 0.2%
(Roche Diagnostics) and trypsin-EDTA 0.2% at 37 C. The resulting homogenate
was filtered through a 70-mm cell strainer. In some experiments, macrophages were
isolated from muscle cell suspension using MACS technology (Miltenyi Biotec).
A negative selection using PE-Ly6G and PE-NK1.1 antibodies and anti-PE mag-
netic beads (to remove neutrophils and NK cells) was followed by a
positive selection of macrophages with magnetic beads coupled with CD11b
antibodies.
Flow cytometry analysis and cell sorting. Cell suspensions were incubated with
anti-mouse FcgII/III receptor (clone 2.4G2, BD Biosciences, 1:100) for 10min at
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Figure 6 | Macrophage infiltration and function during muscle regeneration. Diagram depicting macrophage infiltration and functions during muscle
regeneration in WT, Cx3cr1 / , Ccl2 / and Cx3cr1 / Ccl2 / mice.
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Results are mean±s.e.m. of five mice in two independent experiments. (d) Quantification on day 4 post injury of Ccl2 / myofiber removal in the
absence (n¼ 2) or presence (n¼4) of exogenous human APOE3 protein. (e) Phagocytosis activity of mononuclear phagocytes from injured-muscle of WT,
Cx3cr1 / and Ccl2 / mice on day 4 post injury was assessed 16 h after incubation of muscle cells with CX3CL1 or CCL2 chemokines. The numbers of
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CX3CL1 and CCL2 on IL-1, IL-1 receptor antagonist (Ra) and iNOS (nitric oxide synthase) expression was measured by real-time PCR in mononuclear
phagocytes extracted from WTmice incubated during 16 h with CX3CL1 (100 nM) or CCL2 (100 nM), and compared with untreated cells. Data are
meanþ s.e.m. of six mice per strain in three independent experiments. NS, not significant, *Po0.05, **Po0.01 and ***Po0.001.
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4 C in FACS buffer (Ca2þ /Mg2þ -free PBS with 0.5% BSA) and then stained with
the following fluorescent-conjugated anti-mouse antibodies: V450-Ly6G (clone
1A8, BD Biosciences, 1:100), FITC-CD11c (clone HL3, BD Biosciences, 1:100),
PE-Cy7-NK1.1 (clone PK136, BD Biosciences, 1:100), APC-Cy7-Ly6C (clone
AL-21, BD Biosciences, 1:100), PE-CD64 (clone X54-5/7.1, BD Biosciences, 1:100),
APC-IAb (major histocompatibility complex molecules-class II, clone AF6-120-1,
BD Biosciences, 1:200), PE-SiglecF (clone E50-2440, BD Biosciences, 1:100),
PE-CD206 (clone MR5D3, BD Biosciences, 1:100), biotinylated anti-Mgl1
(MCA2392B, Serotec, 1:100), PE-CCR2 (clone 475301, R&D Systems, 1:100),
PerCP-Cy5.5-CD11b (clone M1/70, ebiosciences, 1:500) and APC-F4/80 (clone
BM8, ebiosciences, 1:150). A PE-streptavidin (1:1,500, BD Biosciences) was
used to reveal Mgl1 expression. Cells were analysed on a FACS Canto II (BD
Biosciences) with Diva and FlowJo softwares. Sorting of macrophage cell subsets
was performed on a FACSAria II cell sorter (BD Biosciences).
Microarray analysis, normalization, data set analysis. The four subsets of
mononuclear phagocytes were sorted from the injured muscle by flow cytometry
on day 4 post injury with the gating strategy showed in Fig. 2. RNA was amplified
with the Ovation Pico WTA system V2 (NuGEN) and the resulting com-
plementary DNA (cDNA) was hybridized on Illumina whole mouse genome oligo
microarrays (WG6 V2.0). Array data were analysed with Genome studio (Illumina)
and MeV software. Filter on background signals and quantile normalization were
applied, and only probe sets showing significance (P-valueo0.05) in 8 of the 16
samples were selected. One-way analysis of variance (Po0.01) with subsequent
hierarchical clustering was performed on median centred log2 intensity of the
resulting 2,472 probes and identified 434 genes that discriminated between the four
cell subsets and spread into 10 clusters. Genes showing differential expression in
Ccl2 / mice compared with WT, Cx3cr1 / and Cx3cr1 / Cc2 / were
selected according to Eisen et al.56 and comparisons are presented with Venn
diagrams (http://bioinfogp.cnb.csic.es/tools/venny/index.html). Ingenuity Pathway
Analysis (IPA; Ingenuity Systems Inc.) software was used to identify metabolic and
signalling pathways.
Quantitative RT–PCR. Total RNA from cell lysates of injured muscles was
extracted using the RNeasy Mini Kit (Qiagen), according to the manufacturer’s
instructions. Reverse transcription was performed on 10 ng of RNA using
SuperScript VILO cDNA Synthesis Kit (Invitrogen). cDNA were quantified by
qPCR using Power SYBR Green PCR Master Mix (Life Technologies) and ApoE,
Cx3cr1, Ccl2, Il-1b, Il-1Ra (receptor antagonist), iNOS primers were added at
250 nM each in a final volume of 20 ml (in duplicate for each sample). The
sequences of primers used are as follows: ApoE-F: 50-CCTGAACCGCTT
CTGGGATT-30, ApoE-R:50-CGTAGATCCTCCATGTCGGC-30 , Cx3cr1-F:
50-TTCAATCCCAAGGCCCTGTC-30, Cx3cr1-R: 50-GTGCAAGCAACAGAGT
TGGG-30 , Il1b-F: 50-CTGTGTCTTTCCCGTGGACC-30 , Il1b-R: 50-CAGCTCATA
TGGGTCCGACA-30 , Il1ra-F:50-TCACCCATGGCTTCAGAGGCAGCC-30,
Il1ra-R: 50-GGCCTTTCTCAGAGCGGATGAAG-30, Inos-F: 50-CCAAGCCC
TCACCTACTTCC-30 , Inos-R: 50-CTCTGAGGGCTGACACAAGG-30 . PCR
(denaturation at 95 C for 10min, followed by 40 cycles of 95 C (15 s) and 60 C
(60 s)) were performed on an ABI7300 (Applied Biosystems). Relative target
gene quantification was normalized to GAPDH as housekeeping gene control
for each sample and to untreated sample for each experiment, using the 2 –DDCt
method.
ELISA assays. Muscles obtained at day 0, 1, 4, 10 and 21 after notexin-injury were
stored at  20 C, thawed and centrifuged to obtain tissue homogenates (1 muscle
in 1ml PBS). Murine ELISA CX3CL1 (Fractalkine) and CCL2 (MCP1) assays
were performed using Quantikine ELISA Mouse Immunoassay kits (Bio-techne)
following the manufacturer’s protocol. ApoE3 was measured in mouse serum on
day 8 post injury with a HRP-human ApoE3 ELISA Kit (Mabtech).
Western blot. Macrophages sorted from injured muscle on day 4 post injury
through MACS technology were pelleted and lysed in PBS pH7.4, 2% Triton X-100,
1% SDS complemented with antiprotease cocktail (Roche). The samples were then
assayed for protein content, diluted in sample loading buffer and heated for
5min at 95 C. Proteins (45 mg per lane) were separated by 4-20% standard
SDS–polyacrylamide gel electrophoresis. Blots were probed with polyclonal
antibodies against ApoE (Abcam, ab20874, 1:750) and tubulin (Millipore, CP06,
50 ngml 1).
Immunolabelling. Frozen muscle cryosections were stained using rabbit
anti mouse-MyoD (M-318, SantaCruz) and monoclonal mouse anti-myogenin
(F5D, DSHB) antibodies (green) were visualized with Alexa Fluor-594- and
-488-conjugated secondary antibodies (Invitrogen) before mounting in Vectashield
mounting medium containing 4,6-diamidino-2-phenylindole (Vector Labora-
tories). Macrophages sorted from injured muscle on day 4 post injury through
MACS technology were spun onto glass slides and kept at  80 C until use.
Apolipoprotein E immunolabelling used a rabbit polyclonal anti-mouse ApoE
(Abcam, 1/30e), and an anti-rabbit Alexa 488 antibody (Life Technology) as a
secondary antibody.
BM transplantation. BM transplantation was performed as follows: donor
BM cells were obtained by flushing femoral and tibial BM of WT, Ccl2 / ,
Cx3cr1 / , Cx3cr1GFP/GFP or Cx3cr1GFP/GFP ApoE / mice with PBS. Cells
were filtered, washed twice and counted in a Malassez slide. 10 106 BM cells
in 0.1ml of PBS was injected retro-orbitally to 10.0-Gy-irradiated Ccl2 / mice
(5 Gy twice, 3 h apart) directly, at the end of the second irradiation. Chimerism was
evaluated on mice engrafted with CX3CR1gfp/gfp or CX3CR1gfp/gfpApoE / BM,
calculating the percentage of GFPþ cells among the total number of CD11bþ
CD115þ F4/80þ monocytes. Muscle injury was performed 10 weeks after BM
transplantation.
Macrophage and MPC culture. Macrophages were obtained from BM precursor
cells. In brief, total BM was obtained from mice by flushing femur and tibia BM
with DMEM. Cells were cultured in a DMEM-containing conditioned medium of
L929 cell line (enriched in M-CSF) for 7 days. After washing, DMEM-serum-free
medium was added for 24 h, and cells were recovered and centrifuged in order to
obtain macrophage-conditioned medium. For phagocytosis studies, cell cultures
were performed under standard conditions in DMEM/F12 (Gibco) containing 20%
FBS and 2% Ultroser G serum (Pall) during 16 h with or without addition of
recombinant recombinant human cytokines CX3CL1 (R&D Systems) or CCL2
(PeproTech) at 100 nM.
Murine MPCs were obtained from TA muscle and cultured with standard
conditions in DMEM/F12 (Gibco) containing 20% FBS and 2% Ultroser G serum
(Pall). For proliferation studies, MPCs were seeded at 10,000 cells per cm2
on Matrigel (1/10) and incubated for 1 day with macrophage-conditioned
mediumþ 2.5% FBS. Then, cells were incubated with anti-ki67 antibodies
(15580, Abcam). For fusion index studies, MPCs were seeded at 30,000 cells per
cm2 on Matrigel (1/10) and incubated for 3 days with macrophage-conditioned
medium containing 2% horse serum. Then, cells were incubated with antibodies
against desmin (32362, Abcam).
Phagocytosis. Macrophage-enriched muscular cell suspensions extracted at day
4 post injury were cultured for 4 h with red fluorescent (580/605) Fluospheres
carboxylate-modified microspheres (0.2 mm size) at a 1:10 ratio (macrophage/
microspheres) in six-well plates. Cells were analysed on a Zeiss inverted fluorescent
axio observer Z1 microscope. Phagocytosis was expressed as the number of
macrophages containing at least one microsphere per 1,000 cells, counted using
and Image J software, in three distinct experiments. For some experiments,
macrophage-enriched muscular cell suspensions were cultured for 16 h with or
without addition of Apolipoprotein E3 (Leinco Technologies) at 10 mgml 1,
recombinant human cytokines CX3CL1 (R&D Systems) or CCL2 (PeproTech)
at 100 nM.
In vivo phagocytosis was assessed on day 4 post injury as the percentage
of phagocytosed myofibers (infiltrated by mononuclear cells) among the total
number of necrotic (not infiltrated)þ phagocytosed myofibers. In some case,
Apolipoprotein E3 was injected in the muscle, twice per day (2 10mg), for 3 days.
Statistical analyses. Data are presented as the mean plus the standard error of the
mean (s.e.m.). Statistical analyses compared the groups with a Mann–Whitney test
or with a Wilcoxon test for matched paired values (Prism software). P values of less
than 0.05 were considered statistically significant.
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